Abstract
dl-2-amino-5-phosphonovaleric acid (AP-5), which blocks glutamatergic transmission at the NMDA-preferring receptor, was injected into the antero-dorsal striatum of rats. AP-5-induced behavioural changes were assessed i) using a stereotypy rating scale and ii) using an experimental chamber designed to quantify sniffing. In both behavioural situations it was shown that AP-5 (10 μg/0.5 μl) induced continuous intensive sniffing similar to that induced by small doses of systemically administered amphetamine or apomorphine. However, oral stereotypies were not induced by AP-5. Systemically injected clozapine (5 and 10 mg/kg SC) as well as haloperidol (0.1 mg/kg IP) antagonized AP-5-induced sniffing. These results show that besides dopamine receptors, NMDA receptors are involved in the control of sniffing. In behavioural terms, the effect of glutamate mediated by the NMDA receptor in the striatum is opposite to that of dopamine.
Similar content being viewed by others
References
Bannon MJ, Roth RH (1983) Pharmacology of mesocortical dopamine neurons. Pharmacol Rev 35:53–68
Björklund A, Lindvall O (1984) Dopamine-containing systems in the CNS. In: Björklund A, Hökfelt T (eds) Handbook of chemical neuroanatomy, vol 2, part I. Elsevier Science, Amsterdam, pp 55–122
Bürki HR, Eichenberger E, Sayers AC, White TG (1975) Clozapine and the dopamine hypothesis of schizophrenia, a critical appraisal. Pharmacopsychiatry 8:115–121
Carter CJ (1980) Glutamatergic pathways from medial prefrontal cortex to the anterior striatum, nucleus accumbens and substantia nigra. Br J Pharmacol 72: 50
Davies J, Evans RH, Jones AW, Mewett KN, Smith DAS, Watkins JC (1983) Recent advances in the pharmacology of excitatory amino acids in the mammilian central nervous system. In: Fuxe K, Roberts P, Schwarcz R (eds) Wenner-Gren Int Symp, vol 39. Macmillan Press, London, pp 43–54
Divac I, Öberg RGE (1979) The neostriatum. Pergamon Press, Oxford New York Toronto
Donzanti BA, Uretsky NJ (1984) Antagonism of the hypermotility response induced by excitatory amino acids in the rat nucleus accumbens. Naunyn-Schmiedeberg's Arch Pharmacol 325:1–7
Fonnum F (1984) Glutamate: A neurotransmitter in mammalian brain. J Neurochem 42:1–11
Fray PJ, Sahakian BJ, Robbins TW, Koob GF, Iversen SD (1980) An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine. Psychopharmacology 69:253–259
Godukhin OV, Zharikova AD, Novoselov VI (1980) The release of labeled l-glutamic acid from rat neostriatum in vivo following stimulation of frontal cortex. Neuroscience 5:2151–2154
Hassler R, Haug P, Nitsch C, Kim JS, Paik K (1982) Effect of motor and premotor cortex ablation on concentrations of amino acids, monoamines, and acetylcholine and on the ultrastructure in rat striatum. A confirmation of glutamate as the specific cortico-striatal transmitter. J Neurochem 38:1087–1098
Havemann U, Turski L, Schwarz M, Kuschinsky K (1983) Nigral GABA ergic mechanisms and EMG activity in rats: Differences between pars reticulata and pars compacta. Eur J Pharmacol 92:49–56
Herrling PL (1985) Pharmacology of the cortico-caudate EPSP in the cat: Evidence for its mediation by quisqualate- or kainate-receptors. Neuroscience 14:417–426
Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507–522
Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmüller B (1980) Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20:379–382
Kornhuber HH (1983) Chemistry, physiology and neuropsychology of schizophrenia: Towards an earlier diagnosis of schizophrenia I. Archiv Psychiatr Nervenkr 233:415–422
Lehmann J, Scatton B (1982) Characterization of the excitatory amino acid receptor-mediated release of [3H]acetylcholine from rat striatal slices. Brain Res 252:77–89
Lehmann J, Schaefer P, Ferkany JW, Coyle JT (1983) Quinolinic acid evokes [3H]acetylcholine release in striatal slices: mediation by NMDA-type excitatory amino acid receptors. Eur J Pharmacol 96:111–115
Lienert GA (1973) Verteilungsfreie Methoden in der Biostatistik, part I. Anton Hain, Meisenheim
Ljungberg T, Ungerstedt U (1978) Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: Evidence for two different mechanisms of action. Psychopharmacology 56:239–247
Meldrum BS, Chapman AG (1983) Excitatory amino acids and anticonvulsant drug action. Glutamine, glutamate, and GABA in the central nervous system. Alan R. Liss Press, New York, pp 625–641
Monoghan DT, Cotman CW (1985) Distribution of N-methyl-D-aspartate-sensitive l-[3H]glutamate-binding sites in rat brain. J Neurosci 11:2909–2919
Nieoullon A, Kerkerian L, Dusticier N (1983) Presynaptic dopaminergic control of high affinity glutamate uptake in the striatum. Neurosci Lett 43:191–196
Olverman HJ, Jones AW, Watkins JC (1984) l-Glutamate has higher affinity than other amino acids for [3H]-d-AP-5 binding sites in rat brain membranes. Nature 307:460–462
Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, Sydney New York London
Pycock CJ, Kerwin RW, Carter CJ (1980) Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 286:74–77
Rebec GV, Bashore TR (1984) Critical issues in assessing the behavioral effects of amphetamine. Neurosci Biobehav Rev 8:153–159
Robertson A, MacDonald C (1984) Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy. Pharmacol Biochem Behav 21:97–101
Rowlands GJ, Roberts PJ (1980a) Activation of dopamine receptors inhibits calcium-dependent glutamate release from corticostriatal terminals in vitro. Eur J Pharmacol 62:241–242
Rowlands GJ, Roberts PJ (1980b) Specific calcium-dependent release of endogenous glutamate from rat striatum is reduced by destruction of the cortico-striatal tract. Exp Brain Res 39:239–240
Sandberg M, Ward HK, Bradford HF (1985) Effect of corticostriate pathway lesion on the activities of enzymes involved in synthesis and metabolism of amino acid neurotransmitters in the striatum. J Neurochem 44:42–47
Scatton B, Lehmann J (1982) N-methyl-d-aspartate-type receptors mediate striatal 3H-acetylcholine release evoked by excitatory amino acids. Nature 297:422–424
Scatton B, Worms P, Lloyd KG, Bartholini G (1982) Cortical modulation of striatal function. Brain Res 232:331–343
Schmidt WJ (1985a) Striatal glutamic acid and behaviour. Neurosci Lett (Suppl 22):93
Schmidt WJ (1985b) Glutamate antagonists induce stereotyped behaviour. Pharmacopsychiatry (in press)
Schmidt WJ (1986) Striatal glutamic acid and the behaviour of the rat. Verh Dtsch Zool Ges (in press)
Sladeczek F, Pin JP, Recasens M, Bockaert J, Weiss S (1985) Glutamate stimulates inositol phosphate formation in striatal neurones. Nature 317:717–719
Spencer H (1976) Antagonism of cortical excitation of striatal neurones by glutamate as an excitatory transmitter in the rat striatum. Brain Res 102:91–101
Stone TW (1979) Amino acids as neurotransmitters of corticofugal neurones in the rat: A comparison of glutamate and aspartate. Br J Pharmacol 67:545–551
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmidt, W.J. Intrastriatal injection of dl-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine. Psychopharmacology 90, 123–130 (1986). https://doi.org/10.1007/BF00172883
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00172883